NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 6 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
SHK Q2 FY27 Concall: H1 Revenue Up 14% to ₹1,299 Cr, EBITDA Rises 33% to ₹168 Cr
S H Kelkar reported a 14% YoY increase in H1 FY27 consolidated revenue to ₹1,299 crore, with Q2 revenue growing 15% YoY to ₹636 crore. H1 EBITDA rose 33% YoY to ₹168 crore, expanding EBITDA margin to 13%. Net debt peaked at ₹911 crore as of September 30, 2026, driven by higher working capital inventory, but management expects debt reduction by March 2027. Capex in Europe is now operational, while the domestic Fragrance factory renewal is slated for Q4 FY27.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the detailed earnings call transcript for the Q2 & H1 FY27 results conducted on November 3, 2026.
ஏன் இது முக்கியம்Provides insights into business segment momentum, margin expansion, international sales traction, and plans to deleverage from the ₹911 crore debt peak.
Q2 FY27 Revenue: Rs.636 croreH1 FY27 Revenue: Rs.1,299 croreH1 FY27 EBITDA: Rs.168 croreNet Debt as of Sep 30, 2026: Rs.911 croreNet Debt vs Net Worth: ~120.2%
📅 குறுகிய காலம்Transcript reflects operational stabilization and margin recovery, though high net debt of ₹911 crore remains an overhang until working capital unwinds.
📈 நீண்ட காலம்Overseas operations (US, UK, Germany) and the commercialization of domestic capex projects in Q4 FY27 and FY28 should support long-term top-line targets of 15% CAGR.
⚠ அபாய எச்சரிக்கைகள்
Elevated net debt of ₹911 crore putting pressure on the balance sheet
Working capital stretch due to high buffer inventory levels
Volatility in raw material prices and global sourcing conditions
👀 கவனிக்க வேண்டியவை
Track inventory normalization and net debt reduction toward March 2027, along with the operational launch of the renewed India fragrance facility in Q4 FY27.
Q2 FY27 Net Profit Jumps 96% to ₹35.7 Cr; Board Approves ₹70 Cr Capex and ₹45 Cr Warrant Issue
Shree Pushkar Chemicals & Fertilisers reported strong Q2 FY27 results in its earnings call, with consolidated revenue rising 58.2% YoY to ₹403.5 crore and PAT up 96.1% YoY to ₹35.7 crore. Growth was led by the chemical business surging 85.6% YoY to ₹245 crore on improved dye stuff realizations, while fertilizer revenues grew 27.5% to ₹158 crore. Operationally, commercial production commenced at Unit 5 (adding ~6,000 MTPA dye capacity) along with a 10 MW solar project. Additionally, the Board approved a fresh ₹70 crore capex for a 3,000 MTPA chemical plant at Unit 5 and a ₹45 crore preferential warrant issue to the promoter at ₹526.90 per warrant.
உச்சம் நம்பிக்கை
என்ன மாறியதுEarnings call transcript released detailing Q2 FY27 financial performance, commissioning of Unit 5 and solar capacity, and approval of a new ₹70 crore capex and ₹45 crore promoter warrant issue.
ஏன் இது முக்கியம்Demonstrates rapid earnings acceleration driven by dye price realizations and capacity additions, positioning the company for its next phase of growth toward an estimated ₹1,800-2,000 crore turnover run-rate over the medium term.
📅 குறுகிய காலம்Strong operational momentum and positive commentary regarding Q3 should support market sentiment, although management noted peak dye stuff margins may attract competing supply over time.
📈 நீண்ட காலம்Integrated manufacturing model, self-funded capex discipline, and capacity additions (Unit 5, Meghnagar fertilizer plant) structurally position the company to scale revenues toward its multi-year targets.
Execution timeline for ongoing capex at Madhya Bharat and Unit 5 expansion (targeted for March 2028)
👀 கவனிக்க வேண்டியவை
Track the ramp-up of the newly commissioned 6,000 MTPA dye capacity at Unit 5 and sustainability of dye stuff realizations in Q3, along with shareholder approval for the ₹45 crore preferential warrant issue.
Shree Pushkar to Issue Rs 45 Cr Warrants to Promoter, Raising Capital Base
Shree Pushkar Chemicals & Fertilisers has issued an EGM notice to seek shareholder approval for issuing 8,54,060 fully convertible warrants on a preferential basis to its CMD and Promoter, Mr. Punit Gopikishan Makharia. The warrants are priced at Rs 526.90 each, aggregating to approximately Rs 45.0 Cr (equivalent to ~2.4% of market cap). Consequently, Mr. Makharia's personal shareholding will increase from 5.04% to 7.32% on a fully diluted basis upon exercise within 18 months. The company also proposes to increase its authorized share capital from Rs 33.50 Cr to Rs 34.00 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company called an EGM to approve an increase in authorized share capital and issue 8,54,060 convertible warrants to the promoter.
ஏன் இது முக்கியம்Promoter infusion of ~Rs 45 Cr demonstrates insider confidence and supports the company's balance sheet for ongoing capacity expansions.
Warrants to be issued: 8,54,060Issue price per warrant: Rs. 526.90Total fundraise value: ~Rs 45.0 CrFundraise vs Market Cap: ~2.4%EGM Date: 2nd டிசம்பர், 2026
📅 குறுகிய காலம்Positive sentiment likely driven by promoter equity commitment at Rs 526.90 per warrant, close to recent market trading levels.
📈 நீண்ட காலம்Strengthens equity net worth to support aggressive capex targets toward FY29 revenue goals of Rs 2,500-3,000 Cr.
⚠ அபாய எச்சரிக்கைகள்
Minor equity dilution of ~2.5% on expanded base
Subject to shareholder approval at the EGM
👀 கவனிக்க வேண்டியவை
Track shareholder voting results at the EGM on December 2, 2026, and monitor the timeline of warrant conversion and upfront 25% cash subscription.
Q2 FY27 PAT Jumps 96.1% to ₹35.7 Cr; ₹70 Cr Expansion & ₹45 Cr Warrant Issue Approved
Shree Pushkar Chemicals & Fertilisers reported strong Q2 FY27 performance, with consolidated revenue rising 58.2% YoY to ₹403.5 crore and PAT expanding 96.1% YoY to ₹35.7 crore. Growth was led by the Chemicals segment, where revenue climbed 85.6% YoY to ₹245 crore despite a 16.8% dip in sales volumes, pointing to higher realizations. In parallel, the Board approved a ₹70 crore capex to add 3,000 MTPA chemical capacity at Ratnagiri Unit 5 by March 2028. To partly fund this, ₹45 crore will be raised via preferential convertible warrants to the promoter CMD at ₹526.90 per warrant.
உச்சம் நம்பிக்கை
என்ன மாறியதுReported strong Q2 FY27 earnings, approved a new ₹70 crore chemical plant capex at Unit 5, and approved a ₹45 crore promoter warrant infusion.
ஏன் இது முக்கியம்Demonstrates sharp operating leverage and margin recovery in chemicals, while the ₹70 crore capex (approx. 7% of TTM revenue) supports long-term capacity expansion.
📅 குறுகிய காலம்Strong operational beat with nearly doubled profits and promoter warrant pricing at ₹526.90 provide solid near-term operational momentum.
📈 நீண்ட காலம்The commercialization of Unit 5 dyes capacity, added solar generation (total 20.6 MW DC), and new 3,000 MTPA chemical capex align with the company's targets to scale chemistry and fertilizer volumes.
⚠ அபாய எச்சரிக்கைகள்
Chemical segment volumes declined 16.8% YoY despite top-line growth, showing heavy reliance on pricing/realizations.
Dilution from 8,54,060 promoter warrants upon future conversion.
👀 கவனிக்க வேண்டியவை
Track shareholder approval for the ₹45 crore promoter warrant issuance and execution updates on the Unit 5 expansion targeted for March 2028.
SHK Q2 FY27 Consolidated Revenue Up 14.9% to ₹636 Cr; PAT Jumps 58.8% to ₹15 Cr
S H Kelkar and Company reported consolidated Q2 FY27 revenue from operations of ₹636 crore, up 14.9% YoY from ₹554 crore. EBITDA rose 49% YoY to ₹79 crore with margins expanding 300 bps to 12.5% (vs 9.5% in Q2 FY26), while PAT grew 58.8% YoY to ₹15 crore. For H1 FY27, revenues reached ₹1,299 crore with PAT at ₹60 crore, up 72.4% YoY. Working capital stretched due to higher inventory holding to manage supply volatility, pushing total borrowings to ₹972.8 crore as of September 30, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுSHK reported Q2 & H1 FY27 results indicating steady top-line growth and margin expansion, alongside peaked debt driven by strategic inventory buildup.
ஏன் இது முக்கியம்Demonstrates operating leverage and pricing power to offset raw material volatility, but elevated leverage requires monitoring against cash conversion.
Q2 FY27 Revenue Grows 15% YoY to ₹632.7 Cr; Net Debt Expands to ₹911 Cr
S H Kelkar reported provisional consolidated revenue of ₹632.7 crore for Q2 FY27, marking a 15% YoY growth compared to Q2 FY26. Gross margins are expected to remain broadly stable YoY despite persistent supply chain volatility and raw material inflationary pressures. However, net debt increased sharply to ₹911 crore as of September 30, 2026, driven by working capital needs and ongoing investments in capacity expansion. The provisional figures are subject to limited review by statutory auditors before full Q2 results.
உச்சம் நம்பிக்கை
என்ன மாறியதுS H Kelkar shared provisional operational metrics for Q2 FY27, reporting 15% revenue growth alongside an increase in net debt to ₹911 crore.
ஏன் இது முக்கியம்Topline growth aligns with management's 15% target, but debt rising to ₹911 crore (representing ~123% of net worth) could pressure net profitability via higher finance costs.
Consolidated Revenue Q2 FY27: Rs. 632.7 கோடிYoY Revenue Growth: 15%Net Debt as of Sep 30, 2026: Rs. 911 கோடிNet Debt to Net Worth: ~123%
📅 குறுகிய காலம்Stable gross margin commentary confirms top-line resilience, but market attention will likely turn to the surge in net debt and its impact on Q2 financing expenses.
📈 நீண்ட காலம்Reaching a 15% revenue CAGR remains positive, but structural re-rating depends on the successful commissioning of capacity investments and demonstrable progress in debt reduction.
⚠ அபாய எச்சரிக்கைகள்
Substantial increase in net debt to ₹911 crore
Supply chain volatility and commodity inflation pressuring margins
👀 கவனிக்க வேண்டியவை
Track the full quarterly earnings release for EBITDA margins and interest costs, and monitor management's timeline and cash-flow roadmap for reducing the elevated debt load.
CRISIL Reaffirms SHK's Rs 372 Cr Bank Loan Rating at 'AA-', Outlook Revised to Negative
Crisil Ratings Limited has reaffirmed S H Kelkar and Company's long-term rating on its bank loan facilities at 'CRISIL AA-'. However, the rating agency revised the outlook from 'Stable' to 'Negative'. The rated amount stands at Rs 372 crore, which represents approximately 84% of the company's total debt of Rs 444 crore. The negative outlook signals potential downward pressure on borrowing costs if operational or leverage metrics deteriorate.
உச்சம் நம்பிக்கை
என்ன மாறியதுCRISIL maintained the long-term credit rating at 'CRISIL AA-' on Rs 372 crore of bank facilities but lowered the rating outlook from 'Stable' to 'Negative'.
ஏன் இது முக்கியம்A negative outlook signals risk of a downgrade, which could increase interest expense and cost of capital on the company's Rs 444 crore debt load.
Rated Bank Facilities: Rs. 372 CroreRevised Rating: CRISIL AA- /NegativeExisting Rating: CRISIL AA- /StableRated debt vs Total debt: ~83.8%
📅 குறுகிய காலம்Marginally negative sentiment for the stock due to the outlook revision to Negative, though the baseline AA- rating remains intact.
📈 நீண்ட காலம்If leverage and operational performance do not strengthen, an eventual downgrade could increase refinancing costs and pressure return ratios.
⚠ அபாய எச்சரிக்கைகள்
Risk of credit rating downgrade within 12-18 months under the Negative outlook
Higher borrowing costs if debt covenants or bank loan pricing are linked to rating revisions
👀 கவனிக்க வேண்டியவை
Track upcoming quarterly operating profit margins and leverage metrics to assess whether the company can avert an actual credit rating downgrade.
SHKSIL Postpones 2 MW Biomass Captive Power Plant Commissioning to October 2026
Shri Hare-Krishna Sponge Iron Limited has informed the exchange that the commencement of commercial production for its 2 MW Biomass Captive Power Plant has been postponed. The company now expects to begin commercial production in October 2026. The exact date of commissioning will be communicated in due course.
உச்சம் நம்பிக்கை
என்ன மாறியதுCommissioning timeline of the 2 MW biomass captive power plant has been delayed to October 2026.
ஏன் இது முக்கியம்Captive biomass power is intended to lower energy costs for sponge iron operations; any delay defers power cost savings.
Captive Plant Capacity: 2 MWExpected Commissioning Month: அக்டோபர் 2026
📅 குறுகிய காலம்Marginally negative sentiment due to project delay, though the postponement is relatively brief (to next month).
📈 நீண்ட காலம்Limited operational impact if successfully commissioned within the revised October 2026 timeline.
⚠ அபாய எச்சரிக்கைகள்
Further execution or commissioning delays
Reason for project delay not disclosed
👀 கவனிக்க வேண்டியவை
Track company disclosures during October 2026 for the revised operational date and subsequent cost savings impact on captive power consumption.
S H Kelkar Chairman and Industry Veteran Ramesh Vaze Passes Away at 85
S H Kelkar and Company Limited announced the sad demise of its Non-Executive Chairman and Promoter, Mr. Ramesh Vaze, on September 15, 2026, at the age of 85. Mr. Vaze had been associated with the company since 1961 (over six decades) and served on the Board since 1981, having previously functioned as Managing Director before transitioning to Non-Executive Chairman in 2019. Operational leadership continues under Whole-Time Director & Group CEO Kedar Vaze, preserving executive business continuity for the Rs 1,882 Cr market cap company.
உச்சம் நம்பிக்கை
என்ன மாறியதுPassing away of Non-Executive Chairman and Promoter Mr. Ramesh Vaze on September 15, 2026.
ஏன் இது முக்கியம்While operational day-to-day leadership is already vested with CEO Kedar Vaze, the company loses its founding visionary, master perfumer, and Board Chairman.
Age of Chairman: 85Years with Company: more than six decadesBoard tenure since: 1981Promoter Holding: 54.87%
📅 குறுகிய காலம்No operational disruptions are anticipated as daily operations are already led by Group CEO Kedar Vaze.
📈 நீண்ட காலம்Limited operational impact, though succession for the Non-Executive Chairman role will follow at the Board level.
⚠ அபாய எச்சரிக்கைகள்
Potential changes in promoter shareholding transmission or governance structure
👀 கவனிக்க வேண்டியவை
Track board announcements regarding the appointment of a new Board Chairman and any long-term estate distribution within the promoter group (which holds 54.87%).
Commercial Production Starts at Unit-5; Adds 6,000 MTPA Dyes Capacity
Shree Pushkar Chemicals & Fertilisers has commenced commercial production at its Unit-5 facility located at MIDC Lote Parshuram, Ratnagiri. The newly commissioned unit adds 6,000 MTPA to the company's Dyes segment capacity, catering to growing market demand. This operationalization supports the company's long-term plan of scaling total revenues toward Rs 2,500-3,000 Cr by FY29 from its current TTM base of Rs 1,002 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுShree Pushkar has officially transitioned its Unit-5 Dyes manufacturing plant from construction/trial stage to commercial operations.
ஏன் இது முக்கியம்The commissioning adds 6,000 MTPA in high-value dyes capacity, expanding output volume and driving top-line growth in line with its multi-year expansion strategy.
📅 குறுகிய காலம்Positive sentiment driver as an ongoing capex milestone is achieved on schedule without visible delays.
📈 நீண்ட காலம்Unit-5 commissioning is a critical building block for the company's targeted FY29 revenue scale of Rs 2,500-3,000 Cr, aiding margins through integrated manufacturing.
⚠ அபாய எச்சரிக்கைகள்
Ramp-up delays or lower-than-expected capacity utilization due to export demand fluctuations
👀 கவனிக்க வேண்டியவை
Track the ramp-up in capacity utilization of Unit-5 and its incremental revenue contribution in the upcoming quarterly results (Q3 FY27 onwards).
SHKSIL Postpones 2 MW Biomass Captive Power Plant Commissioning to End-September 2026
Shri Hare-Krishna Sponge Iron Limited has announced a postponement in the commencement of commercial production for its 2 MW Biomass Captive Power Plant. The company now expects the project to achieve commercial operations by the end of September 2026. The specific operational commencement date will be intimated subsequently.
உச்சம் நம்பிக்கை
என்ன மாறியதுCommercial production start date for the 2 MW captive biomass power plant was deferred to late September 2026.
ஏன் இது முக்கியம்Captive power plants generally help lower operational energy costs for sponge iron operations; delays modestly push back cost optimization benefits.
Plant capacity: 2 MWExpected commercial production: End of September 2026
📅 குறுகிய காலம்Short-term impact is minimal given the delay is roughly one month, though operational benefits will be slightly delayed.
📈 நீண்ட காலம்Once commissioned, the 2 MW captive biomass power project will support captive power needs and energy efficiency.
⚠ அபாய எச்சரிக்கைகள்
Risk of further project execution delays beyond September 2026.
👀 கவனிக்க வேண்டியவை
Track the company's subsequent regulatory filings regarding the final commissioning date by the end of September 2026 and monitor potential power cost savings once operational.
SHKSIL Secures SLDC Approval to Export 3 MW Surplus Power from Captive Power Plant
Shri Hare-Krishna Sponge Iron Limited has received a No Objection Certificate (NOC) from the Chhattisgarh State Load Despatch Centre (SLDC) on August 20, 2026. The approval permits the company to export 3 MW of surplus power generated from its Captive Power Plant. This clearance allows the company to monetize excess electricity generation and optimize plant capacity utilization. Commercial realization will depend on merchant tariffs or power off-take arrangements.
உச்சம் நம்பிக்கை
என்ன மாறியதுReceived regulatory NOC enabling export of 3 MW surplus captive power into the grid.
ஏன் இது முக்கியம்Enables monetization of idle power capacity, creating an incremental revenue stream and improving plant efficiency.
Approved export capacity: 3 MWApproval date: ஆகஸ்ட் 20, 2026Approving authority: Chhattisgarh State Load Despatch Centre (SLDC)
📅 குறுகிய காலம்Positive operational update; monetization will begin once grid injection and billing mechanisms are operational.
📈 நீண்ட காலம்Optimizes asset utilization by monetizing surplus captive generation rather than idling capacity.
⚠ அபாய எச்சரிக்கைகள்
Merchant power tariff volatility and grid evacuation availability
Execution subject to ongoing compliance with SLDC conditions and grid regulations
👀 கவனிக்க வேண்டியவை
Track upcoming quarterly disclosures for commercial power off-take agreements, realized tariffs per unit, and revenue contributions from captive power exports.
Shree Pushkar Q1 FY27 Concall: Guides FY27 Rev to ₹1,350-1,400 Cr, Unit 5 & 6 Trials by Sept
Shree Pushkar Chemicals reported Q1 FY27 revenue growth of 10% YoY to ₹280.10 Cr and PAT growth of 9.4% YoY to ₹22.9 Cr, supported by strong realizations despite lower volumes. Chemical sales value grew 17.1% YoY to ₹138 Cr while fertilizer sales value rose 4% YoY to ₹142 Cr. Management raised its FY27 revenue expectation to ₹1,350–1,400 Cr (vs previous ₹1,200–1,250 Cr) on higher dye intermediate realizations, with K-acid prices surging from ₹550 to ₹700+/kg. Unit 5 and Unit 6 expansions are complete and expected to commence trials by August-September 2026, contributing 4-5 months of operations in FY27.
உச்சம் நம்பிக்கை
என்ன மாறியதுFiled transcript of Q1 FY27 concall providing operational updates on Unit 5/6 commissioning timelines, dye intermediate pricing dynamics, and an upgraded revenue guidance.
ஏன் இது முக்கியம்Higher product realizations and impending commercialization of Unit 5 and 6 capacity provide visibility toward the management's upgraded FY27 revenue projection of ₹1,350-1,400 Cr (up ~38-43% vs FY26 revenue of ₹977 Cr).
📅 குறுகிய காலம்Positive sentiment driven by upgraded revenue guidance and trial timelines for Unit 5 and Unit 6 within the next 4-6 weeks.
📈 நீண்ட காலம்Strengthened backward integration, solar power installations, and major capacity additions across fertilizer (4.5L MTPA) and chemicals (72k MTPA) position the company toward its medium-term growth targets.
⚠ அபாய எச்சரிக்கைகள்
Raw material price volatility (sulfur and ammonia) impacting acid plant run rates
Working capital drag due to advance payment requirements for sulfur vs credit terms for finished acids
Export sensitivity to global supply chain disruptions
👀 கவனிக்க வேண்டியவை
Track the commercial capitalization and trial execution of Unit 5 and Unit 6 over Q2/Q3 FY27, along with the sustainability of elevated K-acid and Vinyl Sulphone export demand.
Shree Pushkar Commissions 10 MW Solar Plant, Total Capacity Reaches 20.6 MW DC
Shree Pushkar Chemicals & Fertilisers has commissioned a 10.00 MW DC solar plant at Shirur, Umri Solar Park in Nanded, Maharashtra. The company also secured Open Access approval from MSEDCL for captive power consumption across Units 1, 2, 3, and 5. With this commissioning, the company's total consolidated solar capacity stands doubled at 20.6 MW DC, which will help optimize power and fuel costs across its core manufacturing facilities.
உச்சம் நம்பிக்கை
என்ன மாறியதுOperationalized a 10.00 MW DC captive solar plant with grid open access approval in Maharashtra.
ஏன் இது முக்கியம்Expands captive renewable energy infrastructure to 20.6 MW DC, reducing industrial power costs and supporting operating profit margins (OPM at 10.2% in FY26).
New Solar Capacity Commissioned: 10.00 MW DCTotal Consolidated Solar Capacity: 20.6 MW DCCaptive Power Units Benefited: Units 1, 2, 3 and 5TTM Revenue Context: Rs 1002 கோடி
📅 குறுகிய காலம்Immediate substitution of higher-cost grid electricity with captive solar power across designated manufacturing units.
📈 நீண்ட காலம்Enhances long-term operational cost competitiveness and improves the company's ESG profile amid ongoing chemical and fertilizer expansions.
⚠ அபாய எச்சரிக்கைகள்
Grid wheeling/transmission charge adjustments by state regulators
Seasonal variation in solar power generation
👀 கவனிக்க வேண்டியவை
Track the upcoming quarterly financial results for power cost savings and operating margin expansion.
Shree Pushkar reported a 10% YoY revenue growth to ₹280.1 cr in Q1 FY27, driven by improved realizations despite a 38.6% YoY drop in chemical sales volumes. EBITDA margins remained stable at 11.4%, with PAT rising 9.4% to ₹22.9 cr. The company is executing a massive capacity expansion, including 4,50,000 MTPA in fertilizers and 72,000 MTPA in chemicals, largely funded through internal accruals and preferential issues. Liquidity remains strong with ₹124.91 cr in non-lien deposits as of June 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company reported its Q1 FY27 financial performance and provided a status update on its multi-year capacity expansion and land acquisition for future growth.
ஏன் இது முக்கியம்The massive capacity expansion (adding ~60% to total capacity) is the primary driver for the company's target to reach ₹2,500-3,000 cr revenue by FY29, representing a significant scale-up from current TTM revenue of ₹977 cr.
📅 குறுகிய காலம்The stock may react positively to the revenue and PAT growth, though the sharp volume decline in chemicals is a point of caution for the next few weeks.
📈 நீண்ட காலம்Structural growth is supported by a zero-waste integrated model and massive capacity additions that could triple revenue by FY29 if execution remains on track.
⚠ அபாய எச்சரிக்கைகள்
Significant volume decline in the chemical segment
👀 கவனிக்க வேண்டியவை
Monitor the commissioning timeline of Ratnagiri Units 5 and 6, which are nearing completion. Investors should also track if the company can sustain high realizations to offset the current volume pressure in the chemical segment.
Sep 18 Set as Record Date for Final Dividend; Board Approves Q1 Results and Auditor Change
Shree Pushkar Chemicals & Fertilisers has fixed September 18, 2026, as the record date for its final dividend for FY25-26. The board also approved the Q1 FY27 financial results and recommended the appointment of M/s JASS & CO LLP as statutory auditors for a 5-year term starting from the 33rd AGM. Additionally, the company announced the resignation of Non-Executive Director Mr. Ramakant Madhav Nayak and the appointment of Mr. Raghav Punit Makharia. These changes come as the company maintains a TTM revenue of Rs 977 Cr and a PAT of Rs 70 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has formalized the timeline for its annual dividend payout and initiated a mandatory rotation of its statutory audit firm after a 10-year tenure by the previous auditor.
ஏன் இது முக்கியம்The announcement provides administrative clarity for shareholders regarding dividend eligibility and ensures corporate governance continuity through the appointment of new auditors and directors.
📅 குறுகிய காலம்The stock may see routine price adjustments around the ex-dividend date; however, the primary focus will be on the Q1 FY27 earnings performance.
📈 நீண்ட காலம்Limited structural impact from this filing; long-term growth remains dependent on the execution of the Unit 8 expansion and the target of Rs 2,500-3,000 Cr revenue by FY29.
👀 கவனிக்க வேண்டியவை
Investors should ensure their holdings are in the demat account by the September 18 record date to be eligible for the dividend. Monitor the upcoming Q1 FY27 detailed results for operational efficiency trends in the Chemicals and Fertilizer segments.
14% Revenue Growth in Q1 FY27; EBITDA Margins Expand to 13.4%
SHK reported a 14% YoY revenue growth to ₹662 crore in Q1 FY27, led by strong performance in the Flavours segment and international markets. EBITDA margins improved to 13.4% from 12.6% YoY, driven by operating leverage despite higher R&D and global expansion costs. Net debt increased by ₹65 crore to ₹852 crore due to strategic inventory buildup and ongoing capacity expansion. Management maintains a double-digit revenue growth guidance for FY27, supported by a pipeline of $1.5M-$2M in the US market.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned from recovery to growth, showing margin expansion and successful traction in international markets like Germany and the US.
ஏன் இது முக்கியம்The improvement in operating margins to 13.4% despite geopolitical headwinds suggests better pricing power and product mix, while the international expansion reduces dependency on the domestic Indian fragrance market.
Q1 வருவாய்: ₹662 கோடிEBITDA லாப வரம்பு: 13.4%Net Debt: ₹852 கோடிInsurance Claim Income: ₹30 கோடிUS Revenue Target (FY27): $1.5 million - $2 millionNet Debt vs Net Worth: 1.15x
📅 குறுகிய காலம்The stock may react positively to the 21% EBITDA growth and margin expansion, though the increase in debt is a minor negative.
📈 நீண்ட காலம்Structural growth is tied to the success of the 'Rest of the World' expansion and the ability to scale the Flavours business to ₹400+ crore annually.
⚠ அபாய எச்சரிக்கைகள்
Rising net debt levels (₹852 crore)
Geopolitical volatility affecting freight and energy costs
Softness in the Global Ingredients business segment
👀 கவனிக்க வேண்டியவை
Monitor the normalization of the Flavours segment revenue in Q2 and the execution of the US market entry target of $1.5M-$2M. Investors should also track the company's progress on deleveraging as net debt has risen to ₹852 crore.
14% Revenue Growth in Q1 FY27; EBITDA Margins Expand to 13.4%
SHK reported a 14.1% YoY increase in consolidated revenue to Rs 662.4 crore for Q1 FY27, driven by a robust 63.2% growth in the Flavour segment. EBITDA grew 21.3% to Rs 88.7 crore, with margins expanding to 13.4% from 12.6% YoY due to operating leverage. While the core Fragrance business grew 9%, its EBITDA moderated by 5.1% due to higher R&D and global expansion costs. Management remains committed to double-digit revenue growth for FY27 and long-term deleveraging, with net debt currently at Rs 531 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுSHK has demonstrated a strong start to FY27 with double-digit revenue growth and margin expansion, moving past the operational 'reset' caused by the fire incident in H1 FY25.
ஏன் இது முக்கியம்The results validate the company's strategy of diversifying into international markets (Europe and RoW) and scaling the higher-margin Flavour business, which now contributes significantly to the bottom line.
📅 குறுகிய காலம்The stock may react positively to the margin expansion and strong top-line growth, which aligns with management's long-term 15% growth guidance.
📈 நீண்ட காலம்Structural growth is expected from deeper penetration in US and European markets and a shift toward a more balanced product mix between Fragrances and Flavours.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical uncertainty impacting export markets
Raw material price volatility
High working capital requirements for strategic inventory
👀 கவனிக்க வேண்டியவை
Monitor the sustainability of the high-growth Flavour segment and the impact of raw material price volatility on gross margins. Watch for the company's progress on deleveraging and the execution of its 15% CAGR revenue target through international expansion.
SHK to Divest Non-Core Subsidiary KVPL to Promoter Group for ₹0.46 Cr
S H Kelkar and Company (SHK) has approved the sale of its 100% equity stake in Keva Ventures Private Limited (KVPL) to a promoter group entity, Keva Aromatics Private Limited. The divestment includes KVPL's subsidiary, Amikeva Private Limited, both of which are considered non-core assets. Financially, the impact is minimal as KVPL and Amikeva combined contributed less than 0.05% to SHK's consolidated turnover in FY26. The transaction is valued at ₹45.85 lakhs and is expected to be completed by December 31, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுSHK is exiting its investment in KVPL and its subsidiary Amikeva by selling them to a promoter-owned entity, Keva Aromatics Private Limited.
ஏன் இது முக்கியம்The move simplifies the corporate structure and removes minor loss-making entities from the consolidated books, although the financial scale is negligible compared to SHK's ₹2,082 cr TTM revenue.
Sale Consideration: ₹45,85,000KVPL Revenue Contribution (FY26): 0.04%KVPL Net Worth (Mar 2026): ₹(1.21) crDivestment vs TTM Revenue: ~0.02%Completion Deadline: டிசம்பர் 31, 2026
📅 குறுகிய காலம்The stock is unlikely to see significant movement as the divestment size is immaterial to the company's valuation.
📈 நீண்ட காலம்Structurally positive as it demonstrates management's intent to divest non-core, loss-making units, though the scale is too small to alter the long-term growth trajectory.
⚠ அபாய எச்சரிக்கைகள்
Related-party transaction (sale to promoter group)
Minor loss-making entities being divested
👀 கவனிக்க வேண்டியவை
Investors should note this as a routine portfolio cleanup of immaterial, loss-making subsidiaries; focus remains on the core fragrance and flavor business recovery following previous fire incidents.
13.7% Revenue Growth in Q1 FY27; Net Debt Rises to Rs 864 Cr
S H Kelkar (SHK) reported provisional consolidated revenues of Rs 660 crore for Q1 FY27, marking a 13.7% YoY growth. While gross margins remained stable, the company's net debt surged to approximately Rs 864 crore as of June 30, 2026, compared to Rs 444 crore in the previous financial context. This increase is attributed to planned capacity investments and strategic inventory build-up. The quarterly revenue represents a significant 31.7% of the TTM revenue, indicating a strong seasonal start despite the increased leverage.
உச்சம் நம்பிக்கை
என்ன மாறியதுSHK has reported a double-digit revenue growth for the first quarter of FY27 but has significantly increased its leverage to fund capacity and inventory.
ஏன் இது முக்கியம்The revenue growth aligns with the company's 15% CAGR target, but the spike in net debt (now exceeding the company's net worth of Rs 739 Cr) increases the financial risk profile and may weigh on earnings due to higher interest outgo.
Q1 FY27 Revenue: Rs 660 croreYoY Revenue Growth: 13.7%Net Debt: Rs 864 croreQ1 வருவாய் vs TTM வருவாய்: 31.7%Estimated Debt-to-Equity: 1.17
📅 குறுகிய காலம்The stock may see mixed reactions; the healthy top-line growth is positive, but the substantial increase in debt is likely to cause concern regarding short-term profitability.
📈 நீண்ட காலம்The company is executing its expansion strategy in the US and Europe, but long-term value creation depends on successfully deleveraging and converting the new capacity into higher margins.
⚠ அபாய எச்சரிக்கைகள்
High leverage (Net debt of Rs 864 Cr vs Net worth of Rs 739 Cr)
Interest cost pressure on PAT
Inventory build-up risk
👀 கவனிக்க வேண்டியவை
Investors should monitor the full Q1 results to assess the impact of higher interest costs on net profit given the sharp rise in debt. Watch for management's guidance on the inventory liquidation timeline and the expected return on the new capacity investments.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
